As a result there is a demand by the health care systems for organisations to develop a deeper understanding on how treatments are being used post-approval and the outcomes that patients are receiving outside of the clinical trial setting.
Our team at Axcellant have been involved in designing and executing some of the largest real world post-marketing observational studies. We have a depth of understanding on health care payer and patient perspectives and can add significant value in the generation of real world evidence.
Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October…
Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study…
Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…
Copyright @ 2025 Axcellant. Designed By Frantic